Trade Summary

Yesterday, Dube Eric M, serving as CEO at Travere Therapeutics, Inc. (TVTX), sold 22,500 shares at $43.95 per share, for a total transaction value of $988,875.00. Following this transaction, Dube Eric M now holds 432,886 shares of TVTX.

This sale represents a 5.00% decrease in Dube Eric M's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 6, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, meaning the disclosure happened on the same day as the trade.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.